{"id":"placebo-nasal-spray","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL14012","moleculeType":"Small molecule","molecularWeight":"218.30"},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=placebo nasal spray","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T05:34:08.696992+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T05:34:14.090138+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=placebo nasal spray","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T05:34:14.635829+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL14012/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T05:34:15.389781+00:00"}},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo products are inert formulations designed to mimic active medications in appearance and administration route. When administered as a nasal spray, they may produce symptom relief through psychological mechanisms including expectation, conditioning, and natural disease resolution. Placebos are typically used in clinical research as control comparators to establish the true efficacy of active drugs.","oneSentence":"A placebo nasal spray contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:10.102Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:34:17.053550+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05921448","phase":"EARLY_PHASE1","title":"Vaccine Pandemic Preparedness Through Airway Immunology Characterization","status":"ACTIVE_NOT_RECRUITING","sponsor":"Copenhagen Respiratory Research","startDate":"2025-05-19","conditions":"Influenza, Human","enrollment":60},{"nctId":"NCT06338995","phase":"PHASE3","title":"A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2024-04-29","conditions":"Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)","enrollment":510},{"nctId":"NCT06850805","phase":"PHASE3","title":"Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps","status":"RECRUITING","sponsor":"Optinose US Inc.","startDate":"2025-07-28","conditions":"Chronic Rhinosinusitis Without Nasal Polyps","enrollment":84},{"nctId":"NCT03794076","phase":"PHASE1, PHASE2","title":"Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia","status":"RECRUITING","sponsor":"Vishwajit Nimgaonkar, MD PhD","startDate":"2019-04-01","conditions":"Schizophrenia, Schizo Affective Disorder","enrollment":160},{"nctId":"NCT07466173","phase":"NA","title":"The Importance of Insulin Action in the Brain for the Immune System During Physical Activity-Overweight","status":"NOT_YET_RECRUITING","sponsor":"University of Ulm","startDate":"2026-04","conditions":"Insulin Sensitivity","enrollment":8},{"nctId":"NCT07475546","phase":"PHASE3","title":"Combination Gerotherapeutic Interventions for Healthspan Improvement","status":"ACTIVE_NOT_RECRUITING","sponsor":"AgelessRx","startDate":"2025-07-23","conditions":"Healthspan Improvement, Aging, Longevity","enrollment":30},{"nctId":"NCT07465965","phase":"PHASE1","title":"A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults","status":"RECRUITING","sponsor":"Shanghai World Leader Pharmaceutical Co., Ltd.","startDate":"2026-03-02","conditions":"Overweight, Obesity","enrollment":60},{"nctId":"NCT05275686","phase":"PHASE2","title":"Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2022-04-20","conditions":"Eustachian Tube Dysfunction","enrollment":80},{"nctId":"NCT06834347","phase":"PHASE3","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-02-12","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":210},{"nctId":"NCT06834360","phase":"PHASE3","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-02-06","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":210},{"nctId":"NCT06076304","phase":"PHASE4","title":"Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis","status":"RECRUITING","sponsor":"Daniel Merenstein","startDate":"2023-11-21","conditions":"Sinus Infection, Acute Sinusitis","enrollment":3720},{"nctId":"NCT04851301","phase":"PHASE1, PHASE2","title":"Neural Mechanisms of Immersive Virtual Reality in Chronic Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2021-11-01","conditions":"Pain, Virtual Reality, Placebo","enrollment":259},{"nctId":"NCT06954428","phase":"PHASE1","title":"Clinical Trial of Intranasal Delivery of NT-301","status":"COMPLETED","sponsor":"Nano PharmaSolutions Australia","startDate":"2025-06-20","conditions":"Tolerability of NT-301 Nasal Spray, Pharmacokinetics of NT-301 Nasal Spray, Safety of NT-301 Nasal Spray","enrollment":49},{"nctId":"NCT04903002","phase":"PHASE2, PHASE3","title":"Evaluating the Efficacy of Intranasal Oxytocin on Chronic Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial University of Newfoundland","startDate":"2022-04-01","conditions":"Chronic Pain","enrollment":336},{"nctId":"NCT06295640","phase":"NA","title":"Relative Contribution of Brain Insulin Action for Postprandial Metabolism","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Ulm","startDate":"2024-03-18","conditions":"Glucose Metabolism Disorders","enrollment":31},{"nctId":"NCT06489548","phase":"PHASE2","title":"Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2025-09-16","conditions":"Dementia, Alzheimers Disease, Mild Cognitive Impairment Due to Alzheimer's Disease","enrollment":16},{"nctId":"NCT07222670","phase":"PHASE2","title":"A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing Respiratory Illness Due to Viral Infections in Healthy Adults 18 to 45 Years of Age","status":"RECRUITING","sponsor":"ENA Respiratory Pty Ltd","startDate":"2025-12-04","conditions":"Viral Respiratory Infection, Viral Respiratory Illnesses","enrollment":1100},{"nctId":"NCT07399717","phase":"NA","title":"Assessing Role of Probiotics in Children Aged 6-36 Months Treated for Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Anabio R&D","startDate":"2026-01-26","conditions":"Pneumonia, Pneumonia in Children","enrollment":330},{"nctId":"NCT07398612","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Human Adipose-Derived Stem Cell Exosomes in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2026-01-31","conditions":"Acute Ischemic Stroke","enrollment":60},{"nctId":"NCT04404192","phase":"PHASE2","title":"PH94B in the Treatment of Adjustment Disorder With Anxiety","status":"COMPLETED","sponsor":"VistaGen Therapeutics, Inc.","startDate":"2021-10-12","conditions":"Adjustment Disorder With Anxious Mood","enrollment":41},{"nctId":"NCT06454240","phase":"PHASE2","title":"A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2024-07-17","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":79},{"nctId":"NCT06809179","phase":"PHASE2","title":"A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder","status":"RECRUITING","sponsor":"VistaGen Therapeutics, Inc.","startDate":"2025-01-09","conditions":"Social Anxiety Disorder","enrollment":60},{"nctId":"NCT06615557","phase":"PHASE3","title":"Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)","status":"RECRUITING","sponsor":"VistaGen Therapeutics, Inc.","startDate":"2024-09-16","conditions":"Social Anxiety Disorder (SAD)","enrollment":236},{"nctId":"NCT06705140","phase":"PHASE3","title":"A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers","status":"TERMINATED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2024-11-25","conditions":"RSV Immunisation","enrollment":947},{"nctId":"NCT06252285","phase":"PHASE3","title":"Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers","status":"TERMINATED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2024-02-06","conditions":"RSV Immunisation","enrollment":6300},{"nctId":"NCT06397768","phase":"PHASE3","title":"Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers","status":"TERMINATED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2024-05-13","conditions":"RSV Immunization","enrollment":2226},{"nctId":"NCT01471184","phase":"NA","title":"The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo","status":"COMPLETED","sponsor":"Bitop AG","startDate":"2009-09","conditions":"Allergic Rhinitis, Allergic Conjunctivitis","enrollment":46},{"nctId":"NCT07304518","phase":"PHASE2","title":"Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults","status":"RECRUITING","sponsor":"Sichuan Purity Pharmaceutical Technology Co., Ltd.","startDate":"2026-01-26","conditions":"Migraine","enrollment":456},{"nctId":"NCT05687279","phase":"PHASE1, PHASE2","title":"Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA)","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2023-02-06","conditions":"Respiratory Syncytial Virus Infection","enrollment":80},{"nctId":"NCT07193901","phase":"PHASE2","title":"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or Behavior","status":"RECRUITING","sponsor":"Sichuan Purity Pharmaceutical Technology Co., Ltd.","startDate":"2025-05-27","conditions":"Major Depressive Disorder (MDD","enrollment":98},{"nctId":"NCT07350928","phase":"PHASE3","title":"Observation of the Effect of Preoperative Use of Dexmedetomidine Hydrochloride Nasal Spray on Optimizing Awake Sedation During Breast-Conserving Surgery for Breast Cancer and Postoperative Awake Status","status":"RECRUITING","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2025-03-01","conditions":"Breast Cancer","enrollment":394},{"nctId":"NCT07345442","phase":"PHASE1","title":"Study on the Safety, Tolerability, and Pharmacokinetics of PA9159 Nasal Spray in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Anhui Palo Alto Pharmaceuticals, Inc.","startDate":"2025-03-14","conditions":"Allergic Rhinitis","enrollment":36},{"nctId":"NCT06716021","phase":"PHASE3","title":"ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3","status":"NOT_YET_RECRUITING","sponsor":"Milestone Pharmaceuticals Inc.","startDate":"2027-01","conditions":"Atrial Fibrillation","enrollment":750},{"nctId":"NCT04218409","phase":"EARLY_PHASE1","title":"Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination","status":"RECRUITING","sponsor":"University of Florida","startDate":"2021-09-02","conditions":"Pain","enrollment":45},{"nctId":"NCT06130449","phase":"EARLY_PHASE1","title":"Testosterone and Neural Function","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-04-01","conditions":"Spinal Cord Injury","enrollment":15},{"nctId":"NCT07324057","phase":"NA","title":"The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavioral Changes in Children With Autism Spectrum Disorder","status":"NOT_YET_RECRUITING","sponsor":"Sun Fei","startDate":"2026-02-01","conditions":"Autism Spectrum Disorder","enrollment":234},{"nctId":"NCT06036004","phase":"PHASE2","title":"Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-01-08","conditions":"Central Diabetes Insipidus (cDI)","enrollment":112},{"nctId":"NCT07298525","phase":"PHASE4","title":"Safety Exploration and Evaluation of Dexmedetomidine Hydrochloride Nasal Spray for Pre-anesthesia Sedation in Low-Monitoring Settings","status":"NOT_YET_RECRUITING","sponsor":"Sichuan Provincial People's Hospital","startDate":"2026-01-10","conditions":"Dexmedetomidine, Sedation, Safety","enrollment":564},{"nctId":"NCT06552130","phase":"NA","title":"The Importance of Insulin Action in the Brain for the Immune System During Physical Activity","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Ulm","startDate":"2024-12-15","conditions":"Insulin Sensitivity","enrollment":20},{"nctId":"NCT04650841","phase":"EARLY_PHASE1","title":"The Role of the Opioid System in Placebo Effects on Pain and Social Rejection","status":"NOT_YET_RECRUITING","sponsor":"Trustees of Dartmouth College","startDate":"2026-09-01","conditions":"Pain, Rejection, Placebo Effect","enrollment":60},{"nctId":"NCT07240922","phase":"PHASE4","title":"The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study","status":"RECRUITING","sponsor":"The University of Hong Kong","startDate":"2025-10-01","conditions":"Influenza","enrollment":600},{"nctId":"NCT07265180","phase":"NA","title":"Oxytocin-Augmented Group Psychotherapy for Patients With Schizophrenia - an Oxytocin-dose Comparison","status":"RECRUITING","sponsor":"Charite University, Berlin, Germany","startDate":"2025-09-08","conditions":"Schizophrenia Spectrum Disorders (SSD)","enrollment":120},{"nctId":"NCT07016516","phase":"PHASE1","title":"A Study to Learn About PRT-064040 Nasal Spray in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Sichuan Purity Pharmaceutical Technology Co., Ltd.","startDate":"2025-06-07","conditions":"Migraine","enrollment":80},{"nctId":"NCT04620369","phase":"PHASE3","title":"Rose Geranium in Sesame Oil Nasal Spray for the Improvement of Nasal Vestibulitis Symptoms in Cancer Patients Receiving Chemotherapy","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2020-11-13","conditions":"Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Nasal Vestibulitis","enrollment":106},{"nctId":"NCT07259538","phase":"PHASE1","title":"A Phase I Study Evaluating the Safety, Tolerability, and Pharmacokinetics of VVN432 Nasal Spray","status":"RECRUITING","sponsor":"VivaVision Biotech, Inc","startDate":"2025-11-06","conditions":"Chronic Rhinosinusitis (CRS)","enrollment":60},{"nctId":"NCT06136390","phase":"NA","title":"OXYMIND: Oxytocin-augmented Group Psychotherapy for Patients With Schizophrenia","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2023-09-30","conditions":"Schizophrenia Spectrum Disorders","enrollment":42},{"nctId":"NCT06358651","phase":"PHASE3","title":"Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)","status":"ACTIVE_NOT_RECRUITING","sponsor":"VistaGen Therapeutics, Inc.","startDate":"2024-03-28","conditions":"Social Anxiety Disorder","enrollment":238},{"nctId":"NCT05011396","phase":"PHASE3","title":"PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2","status":"TERMINATED","sponsor":"VistaGen Therapeutics, Inc.","startDate":"2021-08-30","conditions":"Social Anxiety Disorder","enrollment":228},{"nctId":"NCT07000877","phase":"PHASE4","title":"Nasal Decongestant to Reduce Perioperative Adverse Events in Children With Upper Respiratory Track Infections Having Anesthesia.","status":"RECRUITING","sponsor":"Telethon Kids Institute","startDate":"2025-06-25","conditions":"Perioperative Respiratory Adverse Events, Anesthesia Outcomes","enrollment":200},{"nctId":"NCT05299086","phase":"PHASE3","title":"As Needed Versus Regular Intranasal Corticosteroid in Children With Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2022-04-04","conditions":"Perennial Allergic Rhinitis, Child, Only","enrollment":68},{"nctId":"NCT05664516","phase":"PHASE2","title":"A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-03-07","conditions":"Binge-eating Disorder","enrollment":60},{"nctId":"NCT06691113","phase":"PHASE2","title":"A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2024-12-16","conditions":"Chronic Rhinosinusitis Without Nasal Polyps","enrollment":60},{"nctId":"NCT06364228","phase":"PHASE2","title":"Intranasal Oxytocin Intervention for Caregivers to Persons With Dementia","status":"RECRUITING","sponsor":"University of Nebraska","startDate":"2026-01-05","conditions":"Stress","enrollment":32},{"nctId":"NCT06013241","phase":"PHASE2","title":"A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)","status":"COMPLETED","sponsor":"Insmed Incorporated","startDate":"2023-10-30","conditions":"Chronic Rhinosinusitis Without Nasal Polyps","enrollment":288},{"nctId":"NCT06008860","phase":"PHASE4","title":"A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2023-07-01","conditions":"COVID-19","enrollment":280},{"nctId":"NCT05496465","phase":"PHASE2","title":"Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria Flares","status":"COMPLETED","sponsor":"ARS Pharmaceuticals, Inc.","startDate":"2022-07-28","conditions":"Urticaria","enrollment":24},{"nctId":"NCT07219849","phase":"PHASE2","title":"A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure","status":"RECRUITING","sponsor":"Alixer Nexgen Therapeutics Limited","startDate":"2025-10-17","conditions":"Seasonal Allergic Rhinitis (SAR)","enrollment":164},{"nctId":"NCT07162584","phase":"NA","title":"Oxytocin and Human Defensive Responses in a Dynamic Situation","status":"RECRUITING","sponsor":"University of Electronic Science and Technology of China","startDate":"2025-09-13","conditions":"Healthy","enrollment":80},{"nctId":"NCT06881888","phase":"PHASE1","title":"Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-08-31","conditions":"Diabetic Macular Edema","enrollment":60},{"nctId":"NCT06808516","phase":"PHASE2","title":"Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-07-01","conditions":"Arginine Vasopressin Deficiency, Central Diabetes Insipidus, Oxytocin Deficiency","enrollment":42},{"nctId":"NCT06927999","phase":"PHASE2","title":"An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria","status":"RECRUITING","sponsor":"ARS Pharmaceuticals, Inc.","startDate":"2025-07-09","conditions":"Urticaria Chronic","enrollment":42},{"nctId":"NCT07189572","phase":"PHASE3","title":"Intranasal Corticosteroid Spray for Preventing Otitis Media With Effusion After Radiotherapy in Nasopharyngeal Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2025-10","conditions":"Otitis Media, Otitis Media With Effusion After Nasopharyngeal Carcinoma, Radiotherapy Side Effects","enrollment":168},{"nctId":"NCT07196527","phase":"NA","title":"Evaluation of the Clinical Efficacy of PURESSENTIEL Allergy Protection Nasal Spray (SNPA®) in House Dust Mite Allergic Rhinitis- ACARAY Study","status":"NOT_YET_RECRUITING","sponsor":"Puressentiel","startDate":"2025-11-01","conditions":"Allergic Disorder of Respiratory System","enrollment":20},{"nctId":"NCT05109611","phase":"PHASE3","title":"Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection","status":"TERMINATED","sponsor":"Sanotize Research and Development corp.","startDate":"2021-11-20","conditions":"SARS-CoV-2 Infection","enrollment":1389},{"nctId":"NCT05878093","phase":"PHASE3","title":"Dupilumab in Chinese Adult Participants With CRSwNP","status":"COMPLETED","sponsor":"Sanofi","startDate":"2023-05-16","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":63},{"nctId":"NCT07187141","phase":"PHASE1","title":"Nasal Protollin in Early Symptomatic Alzheimer's Disease","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2021-11-18","conditions":"Alzheimer Disease (AD)","enrollment":16},{"nctId":"NCT03204786","phase":"PHASE2, PHASE3","title":"Intranasal Vasopressin Treatment in Children With Autism","status":"COMPLETED","sponsor":"Stanford University","startDate":"2018-02-20","conditions":"Autism, Autism Spectrum Disorder, ASD","enrollment":157},{"nctId":"NCT04754802","phase":"PHASE3","title":"PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge","status":"COMPLETED","sponsor":"VistaGen Therapeutics, Inc.","startDate":"2021-05-24","conditions":"Social Anxiety Disorder","enrollment":224},{"nctId":"NCT03608163","phase":"PHASE4","title":"Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)","status":"TERMINATED","sponsor":"Albert Einstein College of Medicine","startDate":"2019-01-08","conditions":"Diabetes Mellitus, Type 1, Hypoglycemia, Hypoglycemia Unawareness","enrollment":4},{"nctId":"NCT06173531","phase":"PHASE3","title":"Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"ACADIA Pharmaceuticals Inc.","startDate":"2023-11-27","conditions":"Hyperphagia in Prader-Willi Syndrome","enrollment":170},{"nctId":"NCT06330584","phase":"PHASE2","title":"Administration of Intranasal Midazolam for Anxiety in Palliative Care","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2024-12-20","conditions":"Anxiety, Acute Anxiety, Palliative Care","enrollment":36},{"nctId":"NCT05541510","phase":"PHASE2, PHASE3","title":"Evaluating the Safety and Efficacy of AD17002 Intranasal Spray in Treating Participants With Mild to Moderate COVID-19","status":"TERMINATED","sponsor":"Advagene Biopharma Co. Ltd.","startDate":"2022-12-01","conditions":"COVID-19","enrollment":180},{"nctId":"NCT07162649","phase":"NA","title":"Dexmedetomidine Nasal Spray for the Treatment of Panic Attacks in Adults","status":"NOT_YET_RECRUITING","sponsor":"Yuan Shen","startDate":"2025-09-01","conditions":"Dexmedetomidine","enrollment":400},{"nctId":"NCT07156773","phase":"PHASE2","title":"The Study is Being Conducted to Evaluate the Safety and Efficacy of XJN010 Nasal Spray in Patients With Parkinson's Disease Experiencing Off Episodes","status":"RECRUITING","sponsor":"Guangzhou Novaken Pharm Co., Ltd.","startDate":"2025-09-03","conditions":"Parkinson Disease","enrollment":84},{"nctId":"NCT07146126","phase":"PHASE3","title":"A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis","status":"NOT_YET_RECRUITING","sponsor":"Prime Gene Therapeutics Co., Ltd.","startDate":"2025-09-15","conditions":"Seasonal Allergic Rhinitis, SAR","enrollment":600},{"nctId":"NCT07133802","phase":"PHASE3","title":"Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination","status":"NOT_YET_RECRUITING","sponsor":"Changchun BCHT Biotechnology Co.","startDate":"2025-08","conditions":"Prevention of Influenza","enrollment":6680},{"nctId":"NCT07131683","phase":"PHASE1, PHASE2","title":"hUC-MSC-Exo Therapy for Autoimmune Encephalitis","status":"NOT_YET_RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-11-01","conditions":"Autoimmune Encephalitis","enrollment":38},{"nctId":"NCT02095366","phase":"PHASE4","title":"Intra Nasal Sufentanil Versus Intravenous Morphine for Acute Severe Traumatic Pain Analgesia in Emergency Setting","status":"COMPLETED","sponsor":"University Hospital, Grenoble","startDate":"2013-08-02","conditions":"Severe Traumatic Pain, Numeric Pain Rating Scale > 5 / 10","enrollment":194},{"nctId":"NCT07114107","phase":"NA","title":"Vibroacoustic Therapy With Oscillating Positive Expiratory Pressure in the Treatment of Nasal Congestion","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-08","conditions":"Atopic Rhinitis, Atopic Asthma","enrollment":200},{"nctId":"NCT03593473","phase":"PHASE2","title":"Inhaled Oxytocin and HPA Axis Reactivity","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2019-02-07","conditions":"Depression, Postpartum, Anxiety Disorders, Stress, Psychological","enrollment":109},{"nctId":"NCT02484716","phase":"PHASE2","title":"Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO)","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2015-06","conditions":"Telangiectasia, Hereditary Hemorrhagic, Osler Rendu Disease","enrollment":58},{"nctId":"NCT07103915","phase":"NA","title":"Intranasal Lidocaine Spray Versus Nasogastric Tube Administration in the Emergency Room","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2023-11-01","conditions":"Nasogasrtic Tube Insertion","enrollment":120},{"nctId":"NCT04408183","phase":"PHASE2","title":"GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19)","status":"TERMINATED","sponsor":"GeneOne Life Science, Inc.","startDate":"2020-06-10","conditions":"SARS-CoV 2, Infection","enrollment":184},{"nctId":"NCT06566469","phase":"PHASE4","title":"Dexmedetomidine-esketamine Combined Nasal Administration and Emergence Delirium","status":"COMPLETED","sponsor":"Peking University First Hospital","startDate":"2024-09-02","conditions":"Older Patients, Nasal Administration, Dexmedetomidine","enrollment":340},{"nctId":"NCT04551482","phase":"PHASE2","title":"Oxytocin for Weight Loss in Adolescents","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2021-07-28","conditions":"Obesity, Adolescent, Oxytocin","enrollment":75},{"nctId":"NCT06720220","phase":"PHASE3","title":"Role of Airway Topicalization in Awake Fiberoptic Intubation","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2023-06-01","conditions":"Airway Complication of Anesthesia","enrollment":56},{"nctId":"NCT06849466","phase":"PHASE4","title":"Effect of Perioperative Dexmedetomidine on Chronic Post-Surgical Pain","status":"ENROLLING_BY_INVITATION","sponsor":"Peking Union Medical College Hospital","startDate":"2025-07-01","conditions":"Chronic Post-Surgical Pain","enrollment":364},{"nctId":"NCT05870540","phase":"PHASE2","title":"BPL-003 Efficacy and Safety in Treatment Resistant Depression","status":"COMPLETED","sponsor":"Beckley Psytech Limited","startDate":"2023-09-14","conditions":"Treatment Resistant Depression","enrollment":196},{"nctId":"NCT06436534","phase":"NA","title":"Efficacy and Safety of Ganciclovir Capsules in the Treatment of Refractory Moderate-to-severe Allergic Rhinitis","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2024-05-24","conditions":"Rhinitis, Allergic","enrollment":50},{"nctId":"NCT07045701","phase":"PHASE2, PHASE3","title":"FMXIN002 in Patients at Risk of Anaphylaxis","status":"ENROLLING_BY_INVITATION","sponsor":"Nasus Pharma","startDate":"2025-06-12","conditions":"Anaphylaxis Food","enrollment":30},{"nctId":"NCT07031804","phase":"NA","title":"Expectation Effects on Emotional Processing","status":"NOT_YET_RECRUITING","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2025-06","conditions":"Expectation Effects on Emotional Processing","enrollment":51},{"nctId":"NCT03705793","phase":"PHASE4","title":"Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-01-01","conditions":"Chronic Rhinosinusitis (Diagnosis), Allergic Rhinosinusitis, Chronic Eosinophilic Rhinosinusitis","enrollment":53},{"nctId":"NCT03897998","phase":"PHASE2","title":"Neural Correlates of Hypoalgesia Driven by Observation","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2021-11-01","conditions":"Pain, Virtual Reality, Placebo","enrollment":182},{"nctId":"NCT04870333","phase":"PHASE2, PHASE3","title":"PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V","status":"COMPLETED","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2021-02-19","conditions":"Covid19","enrollment":2240},{"nctId":"NCT06861101","phase":"PHASE2","title":"Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in Adults","status":"COMPLETED","sponsor":"Shanghai JunTop Biosciences Co., LTD","startDate":"2025-02-24","conditions":"Seasonal Allergic Rhinitis","enrollment":370},{"nctId":"NCT06432322","phase":"NA","title":"(GluEsk) Glutamate and Esketamine","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2024-06-14","conditions":"Depression","enrollment":16},{"nctId":"NCT06194851","phase":"PHASE2","title":"Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-10-28","conditions":"Post-Traumatic Stress Disorder (PTSD)","enrollment":240},{"nctId":"NCT06837233","phase":"PHASE2","title":"A Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Prime Gene Therapeutics Co., Ltd.","startDate":"2025-03-12","conditions":"Seasonal Allergic Rhinitis","enrollment":160},{"nctId":"NCT04051619","phase":"PHASE1","title":"Oxytocin, Stress, Craving, Opioid Use Disorder","status":"COMPLETED","sponsor":"Brown University","startDate":"2020-01-06","conditions":"Opioid Use Disorder","enrollment":20},{"nctId":"NCT06676774","phase":"PHASE2","title":"Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-05-16","conditions":"Arginine Vasopressin Deficiency, Diabetes Insipidus","enrollment":42}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL14012"},"_approvalHistory":[],"publicationCount":138,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo","Vehicle","ingredients","Placebo control","EVK-001 Placebo"],"phase":"marketed","status":"active","brandName":"placebo nasal spray","genericName":"placebo nasal spray","companyName":"Organon and Co","companyId":"organon-and-co","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":8,"withResults":4},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:34:17.053550+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}